GTS-21, a nicotinic agonist, protects against neocortical neuronal cell loss induced by the nucleus basalis magnocellularis lesion in rats. (Q48664753)
Jump to navigation
Jump to search
scientific article published in July 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | GTS-21, a nicotinic agonist, protects against neocortical neuronal cell loss induced by the nucleus basalis magnocellularis lesion in rats. |
scientific article published in July 1997 |
Statements
GTS-21, a nicotinic agonist, protects against neocortical neuronal cell loss induced by the nucleus basalis magnocellularis lesion in rats (English)
M Nanri
N Kasahara
J Yamamoto
H Miyake